An Open Label Treatment Extension Study of AMG706

Update Il y a 5 ans
Reference: EUCTR2005-004323-18

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To provide ongoing treatment with AMG 706 monotherapy for those subjects who have completed the planned duration of treatment with AMG 706 on a separate Amgen protocol and demonstrate continuing clinical benefit from AMG 706 therapy. To provide ongoing treatment with AMG 706 for subjects who were not eligible to remain on a separate Amgen protocol for reasons other than AMG 706 intolerance, but continue to experience clinical benefit.


Inclusion criteria

  • Dependent on the previous Amgen protocol the patient has left